SSA
DGX icon

Schonfeld Strategic Advisors’s Quest Diagnostics DGX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,389
Closed -$4.56M – 2273
2025
Q2 		$4.56M Buy
25,389
+8,366
+49% +$1.45M 0.03% 596
2025
Q1 		$2.88M Sell
17,023
-2,077
-11% -$341K 0.02% 773
2024
Q4 		$2.88M Sell
19,100
-15,400
-45% -$2.4M 0.02% 696
2024
Q3 		$5.36M Buy
34,500
+22,740
+193% +$3.4M 0.04% 521
2024
Q2 		$1.61M Buy
+11,760
New +$1.61M 0.01% 1002
2023
Q4 		– Sell
-24,618
Closed -$3M – 1936
2023
Q3 		$3M Buy
+24,618
New +$3.28M 0.02% 702
2023
Q2 		– Sell
-8,417
Closed -$1.19M – 2214
2023
Q1 		$1.19M Sell
8,417
-8,448
-50% -$1.21M 0.01% 882
2022
Q4 		$2.64M Buy
16,865
+1,964
+13% +$282K 0.02% 709
2022
Q3 		$1.83M Buy
14,901
+3,639
+32% +$479K 0.02% 909
2022
Q2 		$1.5M Sell
11,262
-45,238
-80% -$6.16M 0.01% 842
2022
Q1 		$7.73M Buy
56,500
+50,339
+817% +$7.02M 0.07% 324
2021
Q4 		$1.07M Sell
6,161
-3,939
-39% -$599K 0.01% 905
2021
Q3 		$1.47M Buy
+10,100
New +$1.48M 0.02% 817
2021
Q1 		– Sell
-18,130
Closed -$2.16M – 1862
2020
Q4 		$2.16M Sell
18,130
-32,312
-64% -$3.94M 0.03% 582
2020
Q3 		$5.78M Buy
50,442
+32,466
+181% +$3.84M 0.11% 254
2020
Q2 		$2.05M Sell
17,976
-4,590
-20% -$487K 0.05% 398
2020
Q1 		$1.81M Buy
22,566
+7,652
+51% +$792K 0.11% 214
2019
Q4 		$1.59M Sell
14,914
-18,186
-55% -$1.9M 0.04% 384
2019
Q3 		$3.54M Buy
+33,100
New +$3.4M 0.1% 211
2018
Q4 		– Sell
-3,500
Closed -$378K – 1097
2018
Q3 		$378K Sell
3,500
-1,320
-27% -$145K 0.02% 641
2018
Q2 		$530K Buy
+4,820
New +$502K 0.03% 527
2018
Q1 		– Sell
-3,754
Closed -$370K – 801
2017
Q4 		$370K Sell
3,754
-55,432
-94% -$5.25M 0.03% 534
2017
Q3 		$5.54M Buy
59,186
+43,310
+273% +$4.6M 0.51% 55
2017
Q2 		$1.76M Buy
+15,876
New +$1.68M 0.18% 172

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schonfeld Strategic Advisors's DGX Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 25,389 shares — an estimated $4.56M sold.

Schonfeld Strategic Advisors first reported a position in DGX in Q2 2017 and held it in 24 quarters. The position peaked at $7.73M in Q1 2022. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 25,389 Quest Diagnostics shares in Q3 2025, an estimated $4.56M.
  • Schonfeld Strategic Advisors first reported a position in Quest Diagnostics in Q2 2017 and held it in 24 quarters.
  • Schonfeld Strategic Advisors's Quest Diagnostics position peaked at $7.73M in Q1 2022.
  • 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.